Inari Medical, Inc. (NARI)
USD 79.97
(0.0%)
USD 79.97
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 7.11 Million USD | 137.89% |
| 2022 | -18.25 Million USD | -270.97% |
| 2021 | 15.51 Million USD | -39.81% |
| 2020 | 16.4 Million USD | 1304.28% |
| 2019 | 358.15 Thousand USD | 114.6% |
| 2018 | -8.98 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -7.21 Million USD | 56.59% |
| 2024 Q1 | -2.31 Million USD | -1103.06% |
| 2024 Q2 | -10.94 Million USD | -45.77% |
| 2023 Q4 | 561 Thousand USD | -92.81% |
| 2023 FY | - USD | 137.89% |
| 2023 Q3 | 7.8 Million USD | 49.87% |
| 2023 Q2 | 5.2 Million USD | 186.31% |
| 2023 Q1 | 1.81 Million USD | 163.96% |
| 2022 Q2 | -7.04 Million USD | -407.13% |
| 2022 Q1 | -1.38 Million USD | -179.1% |
| 2022 FY | - USD | -270.97% |
| 2022 Q4 | -2.84 Million USD | 62.05% |
| 2022 Q3 | -7.49 Million USD | -6.4% |
| 2021 Q3 | -1.67 Million USD | -133.31% |
| 2021 Q2 | 5.01 Million USD | -41.2% |
| 2021 FY | - USD | -39.81% |
| 2021 Q1 | 8.52 Million USD | 20.76% |
| 2021 Q4 | 1.75 Million USD | 205.15% |
| 2020 Q4 | 7.06 Million USD | 4.64% |
| 2020 Q3 | 6.74 Million USD | 4376.02% |
| 2020 FY | - USD | 1304.28% |
| 2020 Q2 | -157.78 Thousand USD | -103.06% |
| 2020 Q1 | 5.16 Million USD | 324.0% |
| 2019 Q2 | -501.53 Thousand USD | -3.13% |
| 2019 FY | - USD | 114.6% |
| 2019 Q1 | -486.29 Thousand USD | 0.0% |
| 2019 Q4 | 1.21 Million USD | 14.04% |
| 2019 Q3 | 1.06 Million USD | 312.95% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 152.74% |
| Cerus Corporation | -26.53 Million USD | 126.805% |
| OrthoPediatrics Corp. | -8.38 Million USD | 184.871% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 167.778% |
| Talis Biomedical Corporation | -66.04 Million USD | 110.77% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 142.657% |
| Inogen, Inc. | -45.67 Million USD | 115.572% |
| Spectral AI, Inc. | -12.26 Million USD | 158.008% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 114.914% |
| CVRx, Inc. | -38.73 Million USD | 118.365% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 301.616% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 158.751% |
| Orthofix Medical Inc. | -86.98 Million USD | 108.177% |
| Venus Concept Inc. | -26.11 Million USD | 127.239% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 114.291% |
| Bioventus Inc. | -23.07 Million USD | 130.832% |
| BrainsWay Ltd. | -2.31 Million USD | 407.789% |
| Envoy Medical, Inc. | -18.23 Million USD | 139.001% |
| electroCore, Inc. | -17.76 Million USD | 140.051% |
| IceCure Medical Ltd | -15.25 Million USD | 146.633% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 114.297% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 142.199% |
| MaxCyte, Inc. | -44.12 Million USD | 116.119% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 160.505% |
| Nexalin Technology, Inc. | -5.69 Million USD | 224.964% |
| PAVmed Inc | -75.74 Million USD | 109.391% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 113.232% |
| RxSight, Inc. | -41.03 Million USD | 117.333% |
| Sight Sciences, Inc. | -49.41 Million USD | 114.394% |
| SI-BONE, Inc. | -34.44 Million USD | 120.65% |
| TELA Bio, Inc. | -40.63 Million USD | 117.505% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 112.201% |
| Treace Medical Concepts, Inc. | -39 Million USD | 118.235% |
| LivaNova PLC | 39.01 Million USD | 81.769% |
| 908 Devices Inc. | -34.02 Million USD | 120.905% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 106.432% |
| Nemaura Medical Inc. | -7.28 Million USD | 197.611% |
| NeuroPace, Inc. | -22.83 Million USD | 131.151% |
| LENSAR, Inc. | -8.71 Million USD | 181.627% |
| Apyx Medical Corporation | -18.11 Million USD | 139.272% |
| Cutera, Inc. | -136.56 Million USD | 105.209% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 310.444% |
| BioSig Technologies, Inc. | -28.15 Million USD | 125.267% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -182.711% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 133.889% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 98.146% |
| Axonics, Inc. | 7.77 Million USD | 8.514% |
| Outset Medical, Inc. | -153.78 Million USD | 104.625% |
| IRIDEX Corporation | -7.44 Million USD | 195.502% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 107.251% |
| IRadimed Corporation | 20.8 Million USD | 65.804% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 188.229% |
| INVO Bioscience, Inc. | -6.88 Million USD | 203.386% |
| Telesis Bio, Inc. | -40.49 Million USD | 117.566% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 80.606% |
| Varex Imaging Corporation | 67.2 Million USD | 89.415% |
| Quipt Home Medical Corp. | 44.07 Million USD | 83.86% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 165.437% |
| Pulmonx Corporation | -55.09 Million USD | 112.911% |
| Dynatronics Corporation | -976 Thousand USD | 828.785% |
| Modular Medical, Inc. | -17.1 Million USD | 141.589% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 149.106% |
| Semler Scientific, Inc. | 23.58 Million USD | 69.846% |
| InMode Ltd. | 196.28 Million USD | 96.376% |
| Bruker Corporation | 599 Million USD | 98.813% |
| Cytosorbents Corporation | -28.81 Million USD | 124.689% |
| DexCom, Inc. | 916.7 Million USD | 99.224% |
| Align Technology, Inc. | 799.03 Million USD | 99.11% |
| Viveve Medical, Inc. | -20.61 Million USD | 134.501% |
| ZimVie Inc. | 91.07 Million USD | 92.19% |
| Movano Inc. | -29.12 Million USD | 124.422% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 261.366% |
| Nexalin Technology, Inc. | -5.69 Million USD | 224.964% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 301.616% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 103.654% |
| Profound Medical Corp. | -27.12 Million USD | 126.225% |
| Insulet Corporation | 323.6 Million USD | 97.802% |
| enVVeno Medical Corporation | -25.01 Million USD | 128.432% |
| Surmodics, Inc. | 1.18 Million USD | -498.737% |
| iCAD, Inc. | -6.56 Million USD | 208.347% |
| Nuwellis, Inc. | -16.35 Million USD | 143.489% |
| Biotricity, Inc. | -8.82 Million USD | 180.571% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 107.343% |
| Aethlon Medical, Inc. | -11.84 Million USD | 160.03% |
| InspireMD, Inc. | -20.91 Million USD | 134.016% |
| PAVmed Inc. | -75.74 Million USD | 109.391% |
| BIOLASE, Inc. | -15.13 Million USD | 146.985% |
| Beyond Air, Inc. | -59.03 Million USD | 112.05% |
| FONAR Corporation | 28.25 Million USD | 74.823% |
| AxoGen, Inc. | -13.32 Million USD | 153.369% |
| Vivani Medical, Inc. | -26.6 Million USD | 126.733% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 71.016% |
| UFP Technologies, Inc. | 72.74 Million USD | 90.222% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 310.084% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 215.546% |
| Tenon Medical, Inc. | -15.52 Million USD | 145.808% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 146.594% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 117.15% |
| AdaptHealth Corp. | -171.09 Million USD | 104.157% |
| Sintx Technologies, Inc. | -6.6 Million USD | 207.773% |
| NanoVibronix, Inc. | -3.43 Million USD | 307.074% |
| Quanterix Corporation | -38.08 Million USD | 118.675% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 165.437% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -23610.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 102.565% |
| TransMedics Group, Inc. | -7.6 Million USD | 193.555% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 132.681% |
| NeuroMetrix, Inc. | -7.09 Million USD | 200.242% |
| Hyperfine, Inc. | -47.06 Million USD | 115.114% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 112.199% |
| Biomerica, Inc. | -5.99 Million USD | 218.688% |
| Bone Biologics Corporation | 479.57 Thousand USD | -1383.198% |
| AVITA Medical, Inc. | -39.56 Million USD | 117.977% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 177.543% |
| Silk Road Medical, Inc | -45.08 Million USD | 115.779% |